2Grace A A,Carnm A J.Quinidine.N Engl J Meal, 1998,338 : 35-45. 被引量：1
3Priori S G, Napolitano C,Schwartz P J,et al.The elusive link between LQT3 and Brugada syndrome: the role of flecainide chaUenge.Circu- lation,2000,102 : 945-947. 被引量：1
4Beinart R,Michailidis A,Gurevitz O T,et al.ls flecainide dangerous in long QT-3 patients? Pacing Clin Electrophysiol,2009,32 : 143-145. 被引量：1
5Riera A R,Uchida A H,Ferreira C,et aLRelationship among Amio- darone,new class Ⅲantiarrhythmics,miscellaneous agents and acquired long QT syndrome. Circulation,2008,15 : 209-219. 被引量：1
6Li E C,Esterly J S,Pohl S,et al. Drug-induced QT-interval prolonga- tion:considerations for Clinicians.Pharmacotherpy,2010,30 : 684-701. 被引量：1
7Fragakis N,Papadopoulos N,Papanastasiou S,et al.Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.Pacing Clin Eleetrophysiol, 2005,28 : 954- 961. 被引量：1
9Zemrak W R,Kenna G A. Association of antipsychotic and antide- pressant drugs with Q-T interval prolongation. Am J Health-Syst Pharm,2008,65 : 1029-1038. 被引量：1
10Bagnes C,Panchuk P N,Recondo G.Antineoplastic chemotherapy induced QTc prolongation. Current Drug Safety,2010,5 : 93-96. 被引量：1
